Detalhe da pesquisa
1.
Thymoquinone-loaded self-nano-emulsifying drug delivery system against ischemia/reperfusion injury.
Drug Deliv Transl Res
; 14(1): 223-235, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523093
2.
Investigating the Wound-Healing Potential of a Nanoemulsion-Gel Formulation of Pituranthos tortuosus Essential Oil.
Gels
; 10(3)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534573
3.
Life cycle assessment as decision support tool for water reuse in agriculture irrigation.
Sci Total Environ
; 836: 155486, 2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476952
4.
Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses.
PPAR Res
; 2021: 6741290, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34721558
5.
Integrated membrane bioreactors modelling: A review on new comprehensive modelling framework.
Bioresour Technol
; 329: 124828, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621928
6.
Model assessment of the prevailing fouling mechanisms in a submerged membrane anaerobic reactor treating low-strength wastewater.
Bioresour Technol
; 268: 460-469, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30107360
7.
Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.
Metab Syndr Relat Disord
; 8(6): 515-22, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20715933
8.
Elevated liver enzymes in metabolic syndrome are associated with coronary stenosis in a Tunisian population.
Metab Syndr Relat Disord
; 8(3): 249-54, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156075
9.
Metabolic syndrome is a risk factor for coronary artery disease in a tunisian population.
Metab Syndr Relat Disord
; 8(2): 105-12, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900157